| Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma (NCT00531284) | Amgen | 2007-09-01 |
| Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer (NCT00530621) | Eli Lilly and Company | 2007-09-01 |
| Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer (NCT00476216) | University of Alabama at Birmingham | 2007-09-01 |
| Erlotinib and Sunitinib in NSCLC (NCT00581789) | University of Wisconsin, Madison | 2007-08-01 |
| Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC (NCT00517595) | Accelerated Community Oncology Research Network | 2007-08-01 |
| Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening (NCT00607425) | Scottsdale Healthcare | 2007-08-01 |
| Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer (NCT00491699) | Symphony Evolution, Inc. | 2007-08-01 |
| Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC) (NCT01124253) | Shanghai Jiao Tong University School of Medicine | 2007-07-01 |
| Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01026844) | Massachusetts General Hospital | 2007-07-01 |
| A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer (NCT00661778) | Hoffmann-La Roche | 2007-07-01 |
| A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. (NCT00428220) | Pfizer | 2007-07-01 |
| Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT01557959) | Wake Forest University Health Sciences | 2007-07-01 |
| MONET1-MOtesanib NSCLC Efficacy and Tolerability Study (NCT00460317) | Amgen | 2007-07-01 |
| A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g) (NCT00480831) | Genentech, Inc. | 2007-06-01 |
| Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer (NCT00417248) | Nasser Hanna, M.D. | 2007-06-01 |
| Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer (NCT00576914) | Chinese Academy of Sciences | 2007-06-01 |
| Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) (NCT00475098) | Assistance Publique - Hôpitaux de Paris | 2007-06-01 |
| Randomized Customized Adjuvant Chemotherapy (GECP-SCAT) (NCT00478699) | Spanish Lung Cancer Group | 2007-06-01 |
| The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer (NCT00380666) | University of Aarhus | 2007-06-01 |
| Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer (NCT00603057) | University of Michigan Rogel Cancer Center | 2007-05-01 |
| Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC (NCT00499109) | H. Lee Moffitt Cancer Center and Research Institute | 2007-05-01 |
| Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer (NCT01494558) | Chinese Academy of Medical Sciences | 2007-05-01 |
| A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer (NCT00482014) | Eli Lilly and Company | 2007-05-01 |
| Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer (NCT00633724) | Fukushima Medical University | 2007-05-01 |
| A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer (NCT00452413) | Eli Lilly and Company | 2007-05-01 |
| Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer (NCT00509366) | Duke University | 2007-05-01 |
| Phase I Cetuximab and Concurrent Radio-chemotherapy (NCT00522886) | Maastricht Radiation Oncology | 2007-04-01 |
| Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer (NCT00460551) | Genmab | 2007-04-01 |
| Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination. (NCT00516022) | Rambam Health Care Campus | 2007-04-01 |
| Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases (NCT00372775) | Pfizer | 2007-03-01 |
| Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NCT00459342) | National Cancer Institute (NCI) | 2007-03-01 |
| Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy (NCT00452075) | Rigshospitalet, Denmark | 2007-03-01 |
| Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058) (NCT00423449) | Merck Sharp & Dohme LLC | 2007-03-01 |
| A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L) (NCT00434226) | Genentech, Inc. | 2007-03-01 |
| Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR (NCT00446225) | Spanish Lung Cancer Group | 2007-02-15 |
| A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NCT01196078) | Hoffmann-La Roche | 2007-02-01 |
| Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery (NCT00410683) | Gustave Roussy, Cancer Campus, Grand Paris | 2007-02-01 |
| Study of XL281 in Adults With Solid Tumors (NCT00451880) | Exelixis | 2007-02-01 |
| Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients (NCT00457119) | Novartis Pharmaceuticals | 2007-02-01 |
| Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC (NCT00449657) | Leo W. Jenkins Cancer Center | 2007-02-01 |
| Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer (NCT00383331) | Eli Lilly and Company | 2007-02-01 |
| A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. (NCT00432562) | Mast Therapeutics, Inc. | 2007-02-01 |
| A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer (NCT00354562) | Abbott | 2007-02-01 |
| Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers (NCT00409006) | Eli Lilly and Company | 2007-02-01 |
| Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer (NCT01054482) | The First Affiliated Hospital of Guangzhou Medical University | 2007-02-01 |
| Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NCT00752115) | Hamamatsu University | 2007-02-01 |
| Stereotactic Precision And Conventional Radiotherapy Evaluation (NCT01920789) | Ass. Prof. Jan Nyman | 2007-01-01 |
| A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer (NCT00583830) | Human Genome Sciences Inc. | 2007-01-01 |
| Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients (NCT00418886) | Genzyme, a Sanofi Company | 2007-01-01 |
| Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) (NCT00409188) | EMD Serono | 2007-01-01 |
| Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT00378573) | Sanofi | 2007-01-01 |
| A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib (NCT00453362) | Genentech, Inc. | 2006-12-01 |
| Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC (NCT00442026) | Hellenic Oncology Research Group | 2006-12-01 |
| Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy (NCT00415363) | Eli Lilly and Company | 2006-12-01 |
| Safety of Everolimus and Pemetrexed in Lung Cancer Patients (NCT00434174) | Novartis Pharmaceuticals | 2006-12-01 |
| Dendritic Cells in Lung Cancer (NCT00442754) | Herlev Hospital | 2006-12-01 |
| Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen (NCT00316225) | Eli Lilly and Company | 2006-12-01 |
| A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC (NCT00343291) | Eli Lilly and Company | 2006-12-01 |
| Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) (NCT00413283) | Amgen | 2006-12-01 |
| Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer (NCT00347412) | Cellectar Biosciences, Inc. | 2006-11-01 |
| Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV (NCT00614965) | Hellenic Oncology Research Group | 2006-11-01 |
| Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00402051) | Eli Lilly and Company | 2006-11-01 |
| Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer (NCT00367679) | GlaxoSmithKline | 2006-11-01 |
| Chemotherapy for Patients With Non-Small Cell Lung Cancer (NCT00380718) | Eli Lilly and Company | 2006-11-01 |
| A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy (NCT00883181) | Amgen | 2006-11-01 |
| Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL) (NCT00391248) | Ontario Clinical Oncology Group (OCOG) | 2006-11-01 |
| A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES) (NCT00388206) | Genentech, Inc. | 2006-11-01 |
| A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer (NCT00297089) | AbbVie (prior sponsor, Abbott) | 2006-11-01 |
| The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients (NCT00695994) | National University Hospital, Singapore | 2006-10-01 |
| Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer (NCT00654030) | Edward Hirschowitz | 2006-10-01 |
| Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer (NCT00408226) | CASI pharmaceuticals, Inc. | 2006-10-01 |
| Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV (NCT00615758) | Hellenic Oncology Research Group | 2006-10-01 |
| Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) (NCT00391274) | Eli Lilly and Company | 2006-10-01 |
| Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy (NCT00349089) | Thoraxklinik-Heidelberg gGmbH | 2006-09-26 |
| A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy (NCT02013206) | Hoffmann-La Roche | 2006-09-01 |
| Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy (NCT00694603) | Lecia V. Sequist | 2006-09-01 |
| A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT02507375) | Hoffmann-La Roche | 2006-09-01 |
| A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors (NCT00373425) | OSI Pharmaceuticals | 2006-09-01 |
| Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer (NCT00363766) | Eli Lilly and Company | 2006-09-01 |
| Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00370292) | Eli Lilly and Company | 2006-09-01 |
| Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer (NCT00372073) | Cyclacel Pharmaceuticals, Inc. | 2006-08-09 |
| Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy (NCT00364351) | Genzyme, a Sanofi Company | 2006-08-01 |
| The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer (NCT00364663) | National Taiwan University Hospital | 2006-08-01 |
| Concurrent Chemo-radiation Form NSCLC to a Individualized MLD (NCT00572325) | Maastricht Radiation Oncology | 2006-08-01 |
| 131-I-TM-601 Study in Adults With Solid Tumors (NCT00379132) | TransMolecular | 2006-08-01 |
| AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen (NCT00372788) | AstraZeneca | 2006-08-01 |
| A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer (NCT00404703) | Hoffmann-La Roche | 2006-08-01 |
| A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. (NCT01998919) | Hoffmann-La Roche | 2006-08-01 |
| Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients (NCT00350792) | Eli Lilly and Company | 2006-08-01 |
| Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC (NCT00496275) | Genzyme, a Sanofi Company | 2006-08-01 |
| Endobronchial Ultrasound vs Mediastinoscopy in NSCLC (NCT00372203) | University Health Network, Toronto | 2006-07-01 |
| Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) (NCT00356122) | Sanofi | 2006-07-01 |
| Study of XL647 in Subjects With Non-Small-Cell Lung Cancer (NCT00364780) | Kadmon Corporation, LLC | 2006-07-01 |
| Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer (NCT00351039) | H. Lee Moffitt Cancer Center and Research Institute | 2006-07-01 |
| Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer (NCT00362882) | National Cancer Institute (NCI) | 2006-07-01 |
| Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) (NCT00359450) | Bristol-Myers Squibb | 2006-07-01 |
| Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC) (NCT00419042) | Groupe Francais De Pneumo-Cancerologie | 2006-07-01 |
| A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash (NCT00343187) | Allergan | 2006-06-01 |
| High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations (NCT00372515) | David M. Jackman, MD | 2006-06-01 |
| Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer (NCT00731952) | University of Virginia | 2006-06-01 |